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Abstract
Purpose The perfusable tissue index (PTI) is a marker of
myocardial viability. Recent technological advances have
made it possible to generate parametric PTI images from a
single [15O]H2O PET/CT scan. The purpose of this study
was to validate these parametric PTI images.
Methods The study population comprised 46 patients with
documented or suspected coronary artery disease who were
studied with [15O]H2O PET and late gadolinium-enhanced
(LGE) cardiac magnetic resonance imaging (CMR).
Results Of the 736 myocardial segments included, 364
showed some degree of LGE. PTI and perfusable tissue
fraction (PTF) diminished with increasing LGE. The areas
under the curve of the PTI and PTF, used to predict (near)
transmural LGE on CMR, were 0.86 and 0.87, respectively.
Optimal sensitivity and specificity were 91 % and 73 % for
PTI and 69 % and 87 % for PTF, respectively.
Conclusion PTI and PTF assessed with a single [15O]H2O
scan can be utilized as markers of myocardial viability in
patients with coronary artery disease.
Keywords PET/CT . CMR . Perfusable tissue index . Late
gadolinium enhancement
Introduction
Assessment of myocardial viability in patients with coro-
nary artery disease is of great clinical importance, as dys-
functional but viable myocardium has the ability to regain
contractility after coronary revascularization with subse-
quent improvements in cardiac function and prognosis [1].
The perfusable tissue index (PTI) can be used as a marker of
myocardial viability, having been validated in patients with
ischaemic heart disease [2–7]. However, PTI has never been
used in clinical practice, primarily due to the complex
imaging protocol consisting of dynamic [15O]H2O and
[15O]CO scans, together with a transmission scan, and the
lack of high-quality, clinically usable parametric images [6].
Recently, however, a method was developed to derive the
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PTI from a single [15O]H2O PET/CT scan [8]. Given the
current potential of clinical [15O]H2O-based perfusion im-
aging and the rapid growth in the availability of cardiac
PET/CT systems, PTI viability measurements could become
incorporated into clinical practice [9, 10]. Parametric PTI
images derived from [15O]H2O PET/CT scans, however,
have not yet been validated. The purpose of this study was
to compare these novel parametric PTI images with late
gadolinium-enhanced cardiovascular magnetic resonance
(LGE-CMR) imaging, an established method for quantify-
ing scar size and a marker of viability.
Materials and methods
Study population
The study population comprised 46 patients with docu-
mented or suspected coronary artery disease who had been
studied using both PET/CT and CMR within a 2-month
period. All patients were in a stable clinical condition and
no ischaemic events or revascularizations had occurred dur-
ing the period between the two examinations. Patients with
contraindications for PET/CT or CMR (e.g. pacemaker,
claustrophobia, atrial fibrillation) were excluded. The study
was approved by the institutional Medical Ethics Review
Committee, and all participants gave written informed con-
sent prior to inclusion.
PET/CT image acquisition
[15O]H2O scans were acquired using a Gemini TF-64 (Phi-
lips Healthcare, Best, The Netherlands) PET/CT scanner.
[15O]H2O (370 MBq) was injected as a 5-ml bolus
(0.8 ml s−1) followed by a 35-ml saline flush (2 ml s−1),
simultaneously starting a 6-min list mode emission scan.
This scan was followed immediately by a respiration-
averaged slow low-dose (LD) CT scan (55 mAs, rotation
time 1.5 s, pitch 0.825, collimation 16×0.625, acquiring
20 cm in 37 s) during normal breathing. All scans were
checked for misalignment between the LD CT scan and the
[15O]H2O scan; in none of the patients were corrections
needed. Dynamic [15O]H2O images were reconstructed into
22 frames (1×10, 8×5, 4×10, 2×15, 3×20, 2×30, 2×60 s)
using the three-dimensional row action maximum likelihood
algorithm and applying all appropriate corrections for the
scanner, normalization, dead time, decay, scatter, randoms
and attenuation based on the corresponding LD CT scan.
Using CAPP software (Siemens/CTI, Knoxville, TN),
regions of interest (ROIs) of 1 cm diameter were placed over
the ascending aorta in at least ten transaxial image planes of
the frame showing the first pass of the injected bolus. These
ROIs were combined into one volume of interest (VOI) for the
ascending aorta. A second set of ROIs were placed over the
right ventricle (RV) cavity in at least five transaxial planes,
with ROI boundaries at least 1 cm from the RV wall to avoid
spill-in from myocardial activity. Again, these ROIs were
combined into one VOI for the RV. Both VOIs were then
projected onto all dynamic [15O]H2O images, thereby gener-
ating arterial (CA(t)) and RV (CRV(t)) time–activity curves.
PET/CT image analysis
Parametric PTI images were calculated as previously de-
scribed [8]. In brief, parametric images of myocardial blood
flow (MBF), perfusable tissue fraction (PTF), and arterial
and venous blood volume fractions were calculated using a
basis function implementation of the standard single-tissue
compartment model for [15O]H2O [11–14]. Parametric
images of arterial and venous blood volume fractions were
subtracted from normalized CT transmission images, result-
ing in parametric anatomic tissue fraction (ATF) images.
Finally, parametric PTI images were calculated as the ratio
of PTF and ATF images (Fig. 1). All parametric images
were generated using software developed in-house. Finally,
16 myocardial VOIs were defined manually on parametric
PTF images, according to the 16 segments model of the
American Heart Association [15], after which this VOI
template was projected onto the parametric PTI images.
CMR image acquisition
CMR studies were performed on a 1.5-Twhole-body scanner
(Magnetom Sonata or Avanto; Siemens, Erlangen, Germany),
using a six-channel phased-array body coil. After survey
scans, a retrotriggered, balanced steady-state free precession
gradient-echo sequence was used for cine imaging. Image
parameters included: slice thickness 5 mm, slice gap 5 mm,
temporal resolution <50 ms, repetition time 3.2 ms, echo time
1.54 ms, flip angle 60°, typical image resolution 1.3×1.6×
5.0 mm. The cardiac cycle consisted of 20 phases. After
obtaining four-, three- and two-chamber view cines, stacks
of 10 to 12 short-axis slices were acquired to fully cover the
left ventricle (LV). Cine images were acquired during breath-
hold with mild expiration. Contrast images were acquired 10
to 15 min after administration of 0.2 mmol kg−1 gadolinium-
DTPA in the same views as in the cine images, using a two-
dimensional segmented inversion-recovery prepared gradient
echo sequence (TE 4.4 ms, TR 9.8 ms, inversion time 250 to
300 ms, typical voxel size 1.3×1.6×5.0 mm).
CMR image analysis
Images were analysed off-line using the software package
MASS (MR Analytical Software System; Medis, Leiden,
The Netherlands). First, short-axis cine images were
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analysed. The endocardial and epicardial borders of the LV
were outlined manually in both end-diastolic and end-
systolic phases of all short-axis images. Papillary muscles
were included in the LV volume. End-diastolic volume, end-
systolic volume and ejection fraction were computed using
these analyses. Subsequently, the endocardial and epicardial
contours of the LGE images were traced manually. The
amount of fibrosis was calculated using the full-width at
half-maximum method, which defines fibrosis as myocardi-
al tissue with a signal intensity ≥50 % of the maximum
hyperenhancement intensity. If no enhancement was found
in a slice, the maximum signal of the nearest slice with
enhancement was used. If two neighbouring slices showed
enhancement, maximum signals were averaged. All areas of
enhancement were quantified by computer-assisted planim-
etry on each of the short-axis images and the segmental
extent of enhancement was expressed as a percentage of
the segmental area. CMR images were analysed according
to the same 16-segment model as used for the parametric
PET images. Finally, myocardial segments were graded as
viable or nonviable using the previously defined cut-off
value of 50 % LGE per segment [16, 17].
Statistical analysis
Continuous variables are presented as means ± SD, and
categorical data are summarized as frequencies and percen-
tages. Multiple datasets were compared using analysis of
variance (ANOVA), and specific differences were identified
using Student’s t-test with Bonferroni inequality adjustment.
Receiver operating characteristic curves were generated
for PTF, PTI and MBF for the prediction of myocardial
viability assessed by LGE CMR. The area under the
curve (AUC) was considered a measure of accuracy to
discriminate between viable and nonviable myocardium.




Baseline characteristics of the patient population are shown
in Table 1. LGE was seen in the CMR images of 34 patients
(74 %). Of the 736 myocardial segments, 364 (49 %)
showed some degree of LGE.
Fig. 1 Example of short axis
images of (a) blood volume, (b)
ATF (g ml−1), (c) PTF (g ml−1),
and (d) PTI in a patient without
coronary artery disease
Table 1 Patient characteristics (n046)
Characteristic Value
Age (years) 65±10
Gender (male) 36 (78 %)
Previous myocardial infarction 34 (74 %)
LV end-diastolic volume (ml) 226±65
LV end-systolic volume (ml) 135±71
LV ejection fraction (%) 42±16
LV mass (g) 132±39
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PET/CT and CMR parameters
PET/CT and CMR data are summarized in Table 2. There
was a gradual decrease in PTF, PTI and MBF values with
increasing degree of LGE on CMR images (p<0.001 by
ANOVA). ATF values remained relatively constant, except
for a significant decrease in the (near) transmurally
enhanced segments (p<0.001 by ANOVA).
Predictive values for viability
Figure 2 shows a concordant pattern between parametric
PTF, PTI and LGE CMR images in a patient with ischaemic
cardiomyopathy after an anterior myocardial infarction.
Using CMR as a reference, 91 of 364 (25 %) segments
showing some degree of LGE were judged to be nonviable
(LGE >50 %). As shown in Fig. 3, the values of PTF and
PTI for predicting myocardial viability in all 736 segments
were comparable (AUC 0.87, CI 0.83–0.90, and 0.86, CI
0.82–0.91, respectively, p00.541). MBF was able to predict
myocardial viability with less accurate (AUC 0.69, CI 0.63–
0.75, p<0.001). Optimal cut-off values of PTF, PTI and
MBF for predicting (near) transmural LGE on CMR were
0.69 g ml−1, 0.80, and 0.78 ml min−1 g−1 with sensitivities
of 69 %, 91 % and 72 %, and specificities of 87 %, 73 % and
56 %, respectively. Figure 4 shows an example of a patient
with a nontransmural scar and a corresponding relatively
high PTI.
Discussion
The present study was conducted to validate the use of a
parametric myocardial viability imaging technique using
[15O]H2O PET/CT in patients with ischaemic heart disease.
Viability assessed using parametric PTF and PTI imaging
was in good agreement with that assessed using LGE CMR.
Furthermore, these images and myocardial perfusion
Table 2 Segmental PET/CT and LGE data
Extent of LGE (%)
Control (n0372) 0–25 (n0190) 25–50 (n083) 50–75 (n054) ≥75 (n037) p value (ANOVA)
ATF 0.76±0.09 0.77±0.09 0.75±0.11 0.73±0.08 0.68±0.11** <0.001
PTF (g ml−1) 0.72±0.08 0.72±0.09 0.70±0.09 0.60±0.08** 0.51±0.12*** <0.001
PTI 0.91±0.08 0.89±0.09 0.89±0.09 0.77±0.10** 0.70±0.16*** <0.001
MBF (ml g−1 min−1) 1.02±0.30 0.91±0.26* 0.85±0.30* 0.83±0.24* 0.67±0.30** <0.001
*p<0.05 vs. control; **p<0.05 vs. control, 0–25 % LGE and 25–50 % LGE; ***p<0.05 vs. control, 0–25 % LGE, 25–50 % LGE and 50–75 %
LGE.
Fig. 2 Long axis images (a–d) and polar maps (e–h) in a patient with an anterior myocardial infarction: a, e CMR with LGE (arrow, %
transmurality); b, f PTF (g ml−1); c, g PTI; d, h MBF (ml g−1 min−1)
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imaging are obtained simultaneously allowing both myocar-
dial viability and ischaemia to be evaluated in a single
scanning session.
[15O]H2O is generally considered to be the gold standard
for absolute quantification of myocardial perfusion in vivo
[10, 18, 19]. Apart from MBF, [15O]H2O also provides
estimates of the extent of myocardium within a ROI that is
able to exchange water rapidly, i.e. PTF. Subsequently, PTF
can be corrected for partial volume effects by dividing it by
its anatomical counterpart ATF, resulting in PTI [5]. It has
been shown that both PTF and PTI can identify myocardial
scarring and thus can act as markers of viability [6]. Only
recently, however, a method has been developed that ena-
bles generation parametric ATF, PTF and PTI images from a
single [15O]H2O PET/CT scan [8]. This obviates the need
for a separate [15O]CO blood volume scan. In addition,
the traditional (long) transmission scan can be replaced
by a (rapid) low-dose CT scan, thereby shortening the
total scanning time substantially. Now that the method
has been shown to produce high-quality parametric
images, its implementation into clinical practice needs
investigation.
Using the described parametric imaging approach, the
present study demonstrated that ATF was relatively constant
independent of tissue characteristics of the myocardium. Only
in (near) transmurally infarcted segments was ATF signifi-
cantly reduced, most likely due to wall thinning, as ATF is
prone to partial volume effects. In contrast, PTF and PTI
progressively decreased with increasing extent of scarring,
as shown by LGE CMR. These results are in line with those
of previous studies in which reductions in both PTF and PTI
were observed in nonviable scarred myocardium [6]. PTI in
control segments appeared to be somewhat lower than the
expected value of unity for normal segments (0.91±0.08).
This phenomenon has previously been observed in cardiomy-
opathy in both animal experiments and human studies [6, 20].
Slight misalignment between PET and CMR segments may
have occurred to additionally account for this reduction in
PTI. Furthermore, the presence of interstitial fibrosis in dilated
cardiomyopathy may also explain this reduction in ‘normal’
segments that remains undetected on LGE CMR [21, 22].
Taking LGE as a reference, the optimal cut-off values for
discriminating between viable and nonviable myocardium
were 0.69 g ml−1 and 0.80 for PTF and PTI, respectively.
AUC analysis revealed that the diagnostic accuracies with the
two PET parameters were comparable. This suggests that the
use of parametric PTF alone may suffice to assess viability.
Although this would reduce the data processing time, it would
not affect the scanning protocol, as for both parameters a
dynamic [15O]H2O PET scan in combination with a low-dose
CT scan are required. In addition, the sensitivity of PTI
exceeded that of PTF (91 % and 68 %, respectively), whereas
for specificity the opposite pattern was observed (73 % and
78 %, respectively). Although further study is need to deter-
mine the cause of this discrepancy, as a potential clinical marker
of viability PTI may be favoured over PTF to reduce false-
negative findings in patients who might benefit from revascu-
larization. It is of interest to note that, compared to PTF and
PTI, MBF performed relatively poorly in distinguishing viable
from nonviable tissue, rendering it less suitable for viability
imaging. Previous studies have indicated that the optimal cut-
off value for PTI is in the range 0.7–0.9. The threshold ob-
served in the present study corresponds with that range.
Fig. 3 Receiver operator characteristics curves for the abilities of PTF,
PTI and MBF to differentiate between viable and nonviable segments
based on late gadolinium enhancement
Fig. 4 Long axis images in a
patient with a nontransmural
anterior myocardial infarction:
a CMR with LGE; b PTI
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LGE was used as a surrogate end-point of myocardial
viability instead of functional recovery of dysfunctional
myocardium after revascularization. LGE has been shown
to be a good, but not perfect, marker of myocardial viability
[16, 17]. Therefore, the results should be interpreted with
caution, and more studies are warranted to establish the
value of parametric PTI as a viability marker.
Conclusion
PTF and PTI, obtained from a single [15O]H2O PET/CT
scan, can be used as markers of myocardial viability in
patients with coronary artery disease.
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